| Detected | Trial | Change |
|---|---|---|
| 2026-07-07 | NCT07198074 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin… |
Trial sites expanded: 223 -> 228 locations |
| 2026-07-07 | NCT06577441 Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment… |
Trial sites expanded: 140 -> 143 locations |
| 2026-07-07 | NCT07061977 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… |
Trial sites expanded: 290 -> 294 locations |
| 2026-07-03 | NCT03412877 Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors… |
date change Primary completion pushed: 2027-03-23 -> 2028-03-23 |
| 2026-07-03 | NCT03412877 Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors… |
date change Completion pushed: 2028-03-23 -> 2029-03-23 |
| 2026-07-03 | NCT00867464 Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human… |
date change Primary completion pushed: 2026-04-30 -> 2026-12-23 |
| 2026-07-03 | NCT00867464 Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human… |
date change Completion pushed: 2026-04-30 -> 2026-12-23 |
| 2026-07-03 | NCT07391774 Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed… |
Trial sites expanded: 28 -> 36 locations |
| 2026-07-02 | NCT05836584 Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional… |
Enrollment reduced: 240 -> 2 participants |
| 2026-07-02 | NCT05836584 Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional… |
date change Primary completion moved earlier: 2027-10-31 -> 2026-01-20 |
| 2026-07-02 | NCT05836584 Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional… |
date change Completion moved earlier: 2027-10-31 -> 2027-06-28 |
| 2026-07-02 | NCT05211323 A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy… |
date change Primary completion pushed: 2026-06-30 -> 2026-09-30 |
| 2026-07-02 | NCT05211323 A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy… |
date change Completion pushed: 2026-06-30 -> 2026-09-30 |
| 2026-07-02 | NCT07391774 Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed… |
Trial sites expanded: 25 -> 28 locations |
| 2026-07-01 | NCT05237947 Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in… |
date change Primary completion pushed: 2026-05-31 -> 2026-08-31 |
| 2026-07-01 | NCT05237947 Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in… |
date change Completion pushed: 2026-05-31 -> 2026-12-31 |
| 2026-07-01 | NCT06103838 18F-Fluciclovine PET/CT in Multiple Myeloma |
date change Primary completion pushed: 2026-12-06 -> 2027-12-06 |
| 2026-07-01 | NCT06103838 18F-Fluciclovine PET/CT in Multiple Myeloma |
date change Completion pushed: 2031-12-06 -> 2032-12-06 |
| 2026-07-01 | NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies |
Trial completed |
| 2026-07-01 | NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies |
date change Completion moved earlier: 2026-07-01 -> 2026-05-14 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-29 | NCT07672483 IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory… | Phase 1 | Not Yet Recruiting |
| 2026-06-25 | NCT07667400 Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma… | Phase 1/2 | Not Yet Recruiting |
| 2026-06-16 | NCT07649304 AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05237947 | Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in… | Human Papillomavirus-Related Cervical Carcinoma | Active, Not Recruiting |
| Phase 3 | |||
| NCT06589804 | Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… | Metastatic Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT04166409 | A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With… | Low Grade Astrocytoma | Recruiting |
| NCT06524544 | A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus… | Locally Advanced Urothelial Carcinoma | Recruiting |
| NCT06337318 | Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden… | Classic Follicular Lymphoma | Recruiting |
| NCT06422806 | Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for… | Metastatic Dedifferentiated Liposarcoma | Recruiting |
| NCT04269902 | Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT05675410 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Recruiting |
| NCT06058377 | Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… | Anatomic Stage II Breast Cancer AJCC v8 | Recruiting |
| NCT06096844 | Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With… | Advanced Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of… | Ganglioneuroblastoma, Nodular | Recruiting |
| NCT06498635 | Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT07391774 | Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed… | Anatomic Stage II Breast Cancer AJCC v8 | Recruiting |
| NCT04181060 | Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With… | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Recruiting |
| NCT04267848 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT07061977 | Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… | Locally Advanced Cervical Adenocarcinoma | Recruiting |
| NCT07198074 | Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin… | Advanced Endometrial Carcinoma | Recruiting |
| NCT07388524 | Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT00565851 | Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After… | Clear Cell Adenocarcinoma | Active, Not Recruiting |
| NCT01169337 | Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering… | Light Chain Deposition Disease | Active, Not Recruiting |
| NCT01886872 | Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in… | Stage I Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT00098475 | Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With… | DS Stage I Multiple Myeloma | Active, Not Recruiting |
| NCT04530565 | Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or… | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Active, Not Recruiting |
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT00217737 | Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating… | Colon Adenocarcinoma | Active, Not Recruiting |